LONG TERM SAFETY AND EFFICACY OF CAR-T CELL TREATMENT IN REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS - DATA FROM THE FIRST SEVEN PATIENTS

被引：6
|
作者：
Taubmann, J. [1 ,2 ,3 ,4 ]
Mueller, F. [2 ,3 ,4 ,5 ]
Boeltz, S. [1 ,2 ,3 ,4 ]
Voelkl, S. [2 ,3 ,4 ,5 ]
Aigner, M. [2 ,3 ,4 ,5 ]
Kleyer, A. [1 ,2 ,3 ,4 ]
Minnopoulou, I. [1 ,2 ,3 ,4 ]
Locatelli, F. [6 ]
D'agostino, M. A. [7 ]
Gary, R. [2 ,3 ,4 ,5 ]
Krestchmann, S. [2 ,3 ,4 ,5 ]
Kharboutli, S. [2 ,3 ,4 ,5 ]
Mougiakakos, D. [2 ,3 ,4 ,5 ,8 ]
Kroenke, G. [1 ,2 ,3 ,4 ]
Andreas, M. [2 ,3 ,4 ,5 ]
Schett, G. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Klinikum Erlangen Nurnberg, Dept Internal Med 3 Rheumatol & Immunol, Erlangen, Germany
[2] Friedrich Alexander Univ Erlangen Nurnberg, Erlangen, Germany
[3] Friedrich Alexander Univ Erlangen Nuremberg, Deutsch Zentrum Immuntherapie DZI, Erlangen, Germany
[4] Univ Klinikum Erlangen, Erlangen, Germany
[5] Univ Klinikum Erlangen Nurnberg, Dept Internal Med 5 Hematol & Oncol, Erlangen, Germany
[6] Osped Pediat Bambino Gesu, Dept Pediat Onco Hematol & Transfus Med, Bambino Gesu, Rome, Italy
[7] Catholica Univ, Div Rheumatol, Fdn Policlin Univ A Gemelli, Sacred Heart, Rome, Italy
[8] Univ Klin Hamatol & Onkol, Hamatol & Onkol, Univ Klinikum Magdeburg AoR, Magdeburg, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Systemic lupus erythematosus; Remission; Treat to target;
D O I：
10.1136/annrheumdis-2023-eular.3736
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0141
引用
收藏
页码：93 / 94
页数：2
相关论文
共 50 条
  • [31] EFFICACY AND SAFETY OF RITUXIMAB IN THE TREATMENT OF NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS DURING LONG-TERM FOLLOW-UP
    Tsanyan, M.
    Soloviev, S.
    Aleksandrova, E.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1076 - 1077
  • [32] Safety and efficacy of CAR-T cell therapy in patients with autoimmune diseases: a systematic review
    Lakshmi Kattamuri
    Bhavesh Mohan Lal
    Nikhil Vojjala
    Mansi Jain
    Kunal Sharma
    Siddharth Jain
    Samer Al Hadidi
    Rheumatology International, 45 (1)
  • [33] Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus
    Iwata, S.
    Saito, K.
    Hirata, S.
    Ohkubo, N.
    Nakayamada, S.
    Nakano, K.
    Hanami, K.
    Kubo, S.
    Miyagawa, I.
    Yoshikawa, M.
    Miyazaki, Y.
    Yoshinari, H.
    Tanaka, Y.
    LUPUS, 2018, 27 (05) : 802 - 811
  • [34] Safety and Efficacy of BCMA CAR-T Cell Therapy in Older Patients With Multiple Myeloma
    Reyes, Kevin R.
    Huang, Chiung-Yu
    Lo, Mimi
    Arora, Shagun
    Chung, Alfred
    Wong, Sandy W.
    Wolf, Jeffrey
    Olin, Rebecca L.
    Martin, Thomas
    Shah, Nina
    Banerjee, Rahul
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (06): : 350 - 355
  • [35] Safety and Efficacy of CD19 CAR-T Cells for Refractory Systemic Sclerosis: A Phase I Clinical Trial
    Feng, Jingjing
    Hu, Yongxian
    Zhang, Mingming
    Cao, Heng
    Ke, Yini
    Xu, Huijun
    Cui, Jiazhen
    Zhang, Yanlei
    Chang, Alex Hongsheng
    Lin, Jin
    Wei, Guoqing
    Huang, He
    BLOOD, 2022, 140 : 10335 - 10336
  • [36] Possible Factors on Efficacy and Safety of CAR-T Therapy in Relapsed or Refractory Aggressive B-Cell Lymphoma
    Huang, Haiwen
    Jiang, Yibin
    Jin, Zhengming
    Li, Caixia
    Wu, Depei
    BLOOD, 2018, 132
  • [37] Stringent Nationwide Selection Criteria for CAR-T Cell Therapy Ensure Favourable Outcome of Patients with LBCL - First Data from the Austrian CAR-T Network
    Rudzki, Jakob D.
    Jaeger, Ulrich
    Wolf, Dominik
    Petzer, Andreas
    Greil, Richard
    Peters, Christina
    Greinix, Hildegard T.
    Attarbaschi, Andishe
    Buxhofer-Ausch, Veronika
    Girschikofsky, Michael
    Holter, Wolfgang
    Leisch, Michael
    Neumeister, Peter
    Schlenke, Peter
    Schmitt, Clemens A.
    Schwinger, Wolfgang
    Worel, Nina
    Wohlfarth, Philipp
    BLOOD, 2022, 140 : 6661 - 6663
  • [38] B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis
    Tian, Dai-Shi
    Qin, Chuan
    Dong, Ming-Hao
    Heming, Michael
    Zhou, Luo-Qi
    Wang, Wen
    Cai, Song-Bai
    You, Yun-Fan
    Shang, Ke
    Xiao, Jun
    Wang, Di
    Li, Chun-Rui
    Zhang, Min
    Bu, Bi-Tao
    Meyer zu Hoerste, Gerd
    Wang, Wei
    EMBO MOLECULAR MEDICINE, 2024, 16 (04) : 966 - 987
  • [39] New insights in systemic lupus erythematosus: From regulatory T cells to CAR-T-cell strategies
    Doglio, Matteo
    Alexander, Tobias
    Del Papa, Nicoletta
    Snowden, John A.
    Greco, Raffaella
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 150 (06) : 1289 - 1301
  • [40] Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register
    McCarthy, Eoghan M.
    Sutton, Emily
    Nesbit, Stephanie
    White, James
    Parker, Ben
    Jayne, David
    Griffiths, Bridget
    Isenberg, David A.
    Rahman, Anisur
    Gordon, Caroline
    D'Cruz, David P.
    Rhodes, Benjamin
    Lanyon, Peter
    Vital, Edward M.
    Yee, Chee-Seng
    Edwards, Christopher J.
    Teh, Lee-Suan
    Akil, Mohammed
    McHugh, Neil J.
    Zoma, Asad
    Bruce, Ian N.
    RHEUMATOLOGY, 2018, 57 (03) : 470 - 479
12345